ValuationViz

RLAY fund manager activity

Relay Therapeutics, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q2 2021 to Q2 2026.

Q4 2022

ManagerActivitySharesValue% of portfolioFiled
Daniel Loeb - Third PointSold out——0.00%Feb 14, 2023

Q3 2022

ManagerActivitySharesValue% of portfolioFiled
Daniel Loeb - Third PointNew100,000$2,237,0000.04%Nov 14, 2022

Newer quarters · Older quarters